Trichomoniasis screening: Difference between revisions
Jump to navigation
Jump to search
Aysha Aslam (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Routine screening is recommended for | Routine screening is recommended for [[asymptomatic]] [[HIV]]-positive individuals and for all individuals identified as being at increased risk of infection.<ref name=CDT>http://www.cdc.gov/std/tg2015/trichomoniasis.htm Accessed on September 14, 2016</ref><ref name="pmid23322080">{{cite journal| author=Coleman JS, Gaydos CA, Witter F| title=Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies. | journal=Obstet Gynecol Surv | year= 2013 | volume= 68 | issue= 1 | pages= 43-50 | pmid=23322080 | doi=10.1097/OGX.0b013e318279fb7d | pmc=3586271 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23322080 }} </ref> | ||
==Screening== | ==Screening== | ||
Routine screening is recommended | Routine screening is recommended for the following individuals:<ref name=CDT>http://www.cdc.gov/std/tg2015/trichomoniasis.htm Accessed on September 14, 2016</ref><ref name="pmid23322080">{{cite journal| author=Coleman JS, Gaydos CA, Witter F| title=Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies. | journal=Obstet Gynecol Surv | year= 2013 | volume= 68 | issue= 1 | pages= 43-50 | pmid=23322080 | doi=10.1097/OGX.0b013e318279fb7d | pmc=3586271 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23322080 }} </ref> | ||
*HIV positive (annually) | *[[HIV]]-positive (annually) | ||
*Multiple sexual partners | *Multiple sexual partners | ||
*Unprotected sexual intercourse | *Unprotected sexual intercourse | ||
*Illict drug use | *Illict drug use | ||
*Previous history of STD | *Previous history of [[STD]] | ||
*Individuals receiving care in | *Individuals receiving care in high-prevalence areas | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gynecology]] | |||
[[Category:FinalQCRequired]] | |||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
Latest revision as of 00:29, 30 July 2020
|
Trichomoniasis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Trichomoniasis screening On the Web |
|
American Roentgen Ray Society Images of Trichomoniasis screening |
|
Risk calculators and risk factors for Trichomoniasis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Routine screening is recommended for asymptomatic HIV-positive individuals and for all individuals identified as being at increased risk of infection.[1][2]
Screening
Routine screening is recommended for the following individuals:[1][2]
- HIV-positive (annually)
- Multiple sexual partners
- Unprotected sexual intercourse
- Illict drug use
- Previous history of STD
- Individuals receiving care in high-prevalence areas
References
- ↑ 1.0 1.1 http://www.cdc.gov/std/tg2015/trichomoniasis.htm Accessed on September 14, 2016
- ↑ 2.0 2.1 Coleman JS, Gaydos CA, Witter F (2013). "Trichomonas vaginalis vaginitis in obstetrics and gynecology practice: new concepts and controversies". Obstet Gynecol Surv. 68 (1): 43–50. doi:10.1097/OGX.0b013e318279fb7d. PMC 3586271. PMID 23322080.